3.26
price down icon19.51%   -0.79
pre-market  Pre-mercato:  3.23   -0.03   -0.92%
loading

Sonnet Biotherapeutics Holdings Inc Azioni (SONN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
0.0186 0.0373 0.0369 0.0364
Operating Expenses
198.16%
3.8686
1.2975 3.6374 3.9522 5.7012
Benefits Costs and Expenses
0.8217
- - - -
Costs And Expenses
198.16%
3.8686
1.2975 3.6374 3.9522 5.7012
Operating Income/Loss
202.50%
-3.8686
-1.2789 -3.6001 -3.9153 -5.6648
Income/Loss From Continuing Operations Before Tax
131.27%
0.3654
-1.1685 0.0373 0.0369 -5.6671
Income/Loss From Continuing Operations After Tax
131.27%
0.3654
-1.1685 -3.6767 -3.9467 -5.6671
Net Income/Loss
131.27%
0.3654
-1.1685 -3.6767 -3.9467 -5.6671
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
21.59%
4.6177
3.7978 -16.53 29.38 16.51
Diluted Average Shares
28.65%
4.8858
3.7978 -16.53 29.38 -
Basic Earnings Per Share
125.81%
0.08
-0.31 -17.28 -0.13 -0.34
Diluted Earnings Per Share
122.58%
0.07
-0.31 -17.28 -0.13 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Capitalizzazione:     |  Volume (24 ore):